AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/
Authors: DIVGI CR BANDER NH SCOTT AM ODONOGHUE JA SGOUROS G WELT S FINN RD MORRISSEY F CAPITELLI P WILLIAMS JM DELAND D NAKHRE A OOSTERWIJK E GULEC S GRAHAM MC LARSON SM OLD LJ
Citation: Cr. Divgi et al., PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/, Clinical cancer research, 4(11), 1998, pp. 2729-2739
A NOVEL FLUID RESUSCITATION THERAPY FOR HEMORRHAGIC-SHOCK
Authors: ROY JW GRAHAM MC GRIFFIN AM GAINER JL
Citation: Jw. Roy et al., A NOVEL FLUID RESUSCITATION THERAPY FOR HEMORRHAGIC-SHOCK, Shock, 10(3), 1998, pp. 213-217
QUANTITATIVE ASSESSMENT OF BONE-MARROW HEMATOPOIESIS USING PARAMETRICMAGNETIC-RESONANCE-IMAGING
Authors: BALLON D JAKUBOWSKI AA TULIPANO PK GRAHAM MC SCHNEIDER E AGHAZADEH B CHEN QS KOUTCHER JA
Citation: D. Ballon et al., QUANTITATIVE ASSESSMENT OF BONE-MARROW HEMATOPOIESIS USING PARAMETRICMAGNETIC-RESONANCE-IMAGING, Magnetic resonance in medicine, 39(5), 1998, pp. 789-800
AN INVESTIGATION OF THE PHYSICAL CHARACTERISTICS OF GA-66 AS AN ISOTOPE FOR PET IMAGING AND QUANTIFICATION
Authors: GRAHAM MC PENTLOW KS MAWLAWI O FINN RD DAGHIGHIAN F LARSON SM
Citation: Mc. Graham et al., AN INVESTIGATION OF THE PHYSICAL CHARACTERISTICS OF GA-66 AS AN ISOTOPE FOR PET IMAGING AND QUANTIFICATION, Medical physics, 24(2), 1997, pp. 317-326
QUANTITATIVE IMAGING OF I-124 WITH PET
Authors: PENTLOW KS GRAHAM MC LAMBRECHT RM DAGHIGHIAN F BACHARACH SL BENDRIEM B FINN RD JORDAN K KALAIGIAN H KARP JS ROBESON WR LARSON SM
Citation: Ks. Pentlow et al., QUANTITATIVE IMAGING OF I-124 WITH PET, The Journal of nuclear medicine, 37(9), 1996, pp. 1557-1562
BONE-MARROW DOSIMETRY - REGIONAL VARIABILITY OF MARROW-LOCALIZING ANTIBODY
Authors: SGOUROS G JUREIDINI IM SCOTT AM GRAHAM MC LARSON SM SCHEINBERG DA
Citation: G. Sgouros et al., BONE-MARROW DOSIMETRY - REGIONAL VARIABILITY OF MARROW-LOCALIZING ANTIBODY, The Journal of nuclear medicine, 37(4), 1996, pp. 695-698
SPATIAL-MAPPING OF THE PERCENTAGE CELLULARITY IN HUMAN BONE-MARROW USING MAGNETIC-RESONANCE-IMAGING
Authors: BALLON D JAKUBOWSKI AA GRAHAM MC SCHNEIDER E KOUTCHER JA
Citation: D. Ballon et al., SPATIAL-MAPPING OF THE PERCENTAGE CELLULARITY IN HUMAN BONE-MARROW USING MAGNETIC-RESONANCE-IMAGING, Medical physics, 23(2), 1996, pp. 243-250
PURIFICATION AND MOLECULAR ANALYSIS OF AN EXTRACELLULAR GAMMA-GLUTAMYL HYDROLASE PRESENT IN YOUNG TISSUES OF THE SOYBEAN PLANT
Authors: HUANGPU J PAK JH GRAHAM MC RICKLE SA GRAHAM JS
Citation: J. Huangpu et al., PURIFICATION AND MOLECULAR ANALYSIS OF AN EXTRACELLULAR GAMMA-GLUTAMYL HYDROLASE PRESENT IN YOUNG TISSUES OF THE SOYBEAN PLANT, Biochemical and biophysical research communications, 228(1), 1996, pp. 1-6
IMAGE REGISTRATION OF SPECT AND CT IMAGES USING AN EXTERNAL FIDUCIARYBAND AND 3-DIMENSIONAL SURFACE FITTING IN METASTATIC THYROID-CANCER
Authors: SCOTT AM MACAPINLAC H ZHANG JJ DAGHIGHIAN F MONTEMAYOR N KALAIGIAN H SGOUROS G GRAHAM MC KOLBERT K YEH SDJ LAI E GOLDSMITH SJ LARSON SM
Citation: Am. Scott et al., IMAGE REGISTRATION OF SPECT AND CT IMAGES USING AN EXTERNAL FIDUCIARYBAND AND 3-DIMENSIONAL SURFACE FITTING IN METASTATIC THYROID-CANCER, The Journal of nuclear medicine, 36(1), 1995, pp. 100-103
BLENDING POPULATION-FOCUSED CARE WITH PRIMARY-CARE - A CASE-STUDY
Authors: GRAHAM MC CALLENDER D
Citation: Mc. Graham et D. Callender, BLENDING POPULATION-FOCUSED CARE WITH PRIMARY-CARE - A CASE-STUDY, Family & community health, 18(1), 1995, pp. 80-83
A PROSPECTIVE COMPARISON OF SYNTHETIC SERUM SUBSTITUTE AND HUMAN SERUM-ALBUMIN IN CULTURE FOR IN-VITRO FERTILIZATION-EMBRYO TRANSFER
Authors: GRAHAM MC PARTRIDGE AB LEWIS V PHIPPS WR
Citation: Mc. Graham et al., A PROSPECTIVE COMPARISON OF SYNTHETIC SERUM SUBSTITUTE AND HUMAN SERUM-ALBUMIN IN CULTURE FOR IN-VITRO FERTILIZATION-EMBRYO TRANSFER, Fertility and sterility, 64(5), 1995, pp. 1036-1038
CLINICAL-APPLICATIONS OF FUSION IMAGING IN ONCOLOGY
Authors: SCOTT AM MACAPINLAC H ZHANG JJ KALAIGIAN H GRAHAM MC DIVGI CR SGOUROS G GOLDSMITH SJ LARSON SM
Citation: Am. Scott et al., CLINICAL-APPLICATIONS OF FUSION IMAGING IN ONCOLOGY, Nuclear medicine and biology, 21(5), 1994, pp. 775-784
CURRENT STATUS OF RADIOIMMUNOTHERAPY
Authors: LARSON SM DIVGI CR SCOTT A SGOUROS G GRAHAM MC KOSTAKOGLU L SCHEINBERG D CHEUNG NKV SCHLOM J FINN RD
Citation: Sm. Larson et al., CURRENT STATUS OF RADIOIMMUNOTHERAPY, Nuclear medicine and biology, 21(5), 1994, pp. 785-792
ESTRADIOL AND PROGESTERONE PRODUCTION BY CULTURED GRANULOSA-CELLS CRYOPRESERVED FROM IN-VITRO FERTILIZATION PATIENTS
Authors: SLUSS PM LEE KE MATTOX JH SMITH PC GRAHAM MC PARTRIDGE AB
Citation: Pm. Sluss et al., ESTRADIOL AND PROGESTERONE PRODUCTION BY CULTURED GRANULOSA-CELLS CRYOPRESERVED FROM IN-VITRO FERTILIZATION PATIENTS, European journal of endocrinology, 130(3), 1994, pp. 259-264
RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE [RE-186 HEDP] DOSE-ESCALATION STUDY IN PATIENTS WITH METASTASIZED PROSTATE-CANCER - TARGET ORGAN DOSIMETRY, NARROW TOXICITY AND OPTIMIZED DATA-COLLECTION
Authors: GRAHAM MC LIU GB DAGHIGHIAN F YEH SDJ SCHER H CURLEY T LARSON SM
Citation: Mc. Graham et al., RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE [RE-186 HEDP] DOSE-ESCALATION STUDY IN PATIENTS WITH METASTASIZED PROSTATE-CANCER - TARGET ORGAN DOSIMETRY, NARROW TOXICITY AND OPTIMIZED DATA-COLLECTION, The Journal of nuclear medicine, 35(5), 1994, pp. 160000036-160000037
RADIOIMMUNOTHERAPY (RIT) WITH I-131 MONOCLONAL-ANTIBODY (MAB) G250 INMETASTATIC RENAL-CANCER
Authors: DIVGI CR BANDER NH GRAHAM MC SCOTT AM WELT S MOTZER RJ OOSTERWIJK E LARSON SM OLD LJ
Citation: Cr. Divgi et al., RADIOIMMUNOTHERAPY (RIT) WITH I-131 MONOCLONAL-ANTIBODY (MAB) G250 INMETASTATIC RENAL-CANCER, The Journal of nuclear medicine, 35(5), 1994, pp. 160000101-160000101
CLINICAL IMPLEMENTATION OF NEW REGION-SPECIFIC S-VALUES FOR MARROW DOSIMETRY - DOSE DISTRIBUTION VS MEAN MARROW DOSE IN RADIOIMMUNOTHERAPY OF LEUKEMIA
Authors: SGOUROS G STABIN MG JUREIDINI IM SCOTT AS GRAHAM MC LARSON SM SCHEINBERG DA ECKERMAN KF
Citation: G. Sgouros et al., CLINICAL IMPLEMENTATION OF NEW REGION-SPECIFIC S-VALUES FOR MARROW DOSIMETRY - DOSE DISTRIBUTION VS MEAN MARROW DOSE IN RADIOIMMUNOTHERAPY OF LEUKEMIA, The Journal of nuclear medicine, 35(5), 1994, pp. 160000112-160000112
DOSE-VOLUME HISTOGRAM REPRESENTATION OF PATIENT DOSE DISTRIBUTION IN 3-DIMENSIONAL INTERNAL DOSIMETRY
Authors: KOLBERT KS SGOUROS G SCOTT AM BALDWIN B ZHANG J KALAIGIAN H MACAPINLAC HA GRAHAM MC LARSON SM
Citation: Ks. Kolbert et al., DOSE-VOLUME HISTOGRAM REPRESENTATION OF PATIENT DOSE DISTRIBUTION IN 3-DIMENSIONAL INTERNAL DOSIMETRY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000123-160000124
CLINICAL VALIDATION OF SPECT AND CT MRI IMAGE REGISTRATION IN RADIOLABELED MONOCLONAL-ANTIBODY STUDIES OF COLORECTAL-CARCINOMA/
Authors: SCOTT AM MACAPINLAC HA DIVGI CR ZHANG JJ KALAIGIAN H PENTLOW K HILTON S GRAHAM MC SGOUROS G PELIZZARI C CHEN G SCHLOM J GOLDSMITH SJ LARSON SM
Citation: Am. Scott et al., CLINICAL VALIDATION OF SPECT AND CT MRI IMAGE REGISTRATION IN RADIOLABELED MONOCLONAL-ANTIBODY STUDIES OF COLORECTAL-CARCINOMA/, The Journal of nuclear medicine, 35(12), 1994, pp. 1976-1984
REDUCING CARDIOVASCULAR-DISEASE RISK-FACTORS IN A MINORITY POPULATIONTHROUGH EXERCISE
Authors: GRAHAM MC POHLMAN RL
Citation: Mc. Graham et Rl. Pohlman, REDUCING CARDIOVASCULAR-DISEASE RISK-FACTORS IN A MINORITY POPULATIONTHROUGH EXERCISE, Family & community health, 17(3), 1994, pp. 80-84
MURINE AND HUMANIZED CONSTRUCTS OF MONOCLONAL-ANTIBODY M195 (ANTI-CD33) FOR THE THERAPY OF ACUTE MYELOGENOUS LEUKEMIA
Authors: CARON PC SCHWARTZ MA CO MS QUEEN C FINN RD GRAHAM MC DIVGI CR LARSON SM SCHEINBERG DA
Citation: Pc. Caron et al., MURINE AND HUMANIZED CONSTRUCTS OF MONOCLONAL-ANTIBODY M195 (ANTI-CD33) FOR THE THERAPY OF ACUTE MYELOGENOUS LEUKEMIA, Cancer, 73(3), 1994, pp. 1049-1056
A PHASE-1B TRIAL OF HUMANIZED MONOCLONAL-ANTIBODY M195 (ANTI-CD33) INMYELOID-LEUKEMIA - SPECIFIC TARGETING WITHOUT IMMUNOGENICITY
Authors: CARON PC JURCIC JG SCOTT AM FINN RD DIVGI CR GRAHAM MC JUREIDINI IM SGOUROS G TYSON D OLD LJ LARSON SM SCHEINBERG DA
Citation: Pc. Caron et al., A PHASE-1B TRIAL OF HUMANIZED MONOCLONAL-ANTIBODY M195 (ANTI-CD33) INMYELOID-LEUKEMIA - SPECIFIC TARGETING WITHOUT IMMUNOGENICITY, Blood, 83(7), 1994, pp. 1760-1768
DEVELOPMENT OF A METHOD TO MEASURE KINETICS OF RADIOLABELED MONOCLONAL-ANTIBODY IN HUMAN TUMOR WITH APPLICATIONS TO MICRODOSIMETRY - POSITRON EMISSION TOMOGRAPHY STUDIES OF I-124 LABELED 3F8 MONOCLONAL-ANTIBODY IN GLIOMA
Authors: DAGHIGHIAN F PENTLOW KS LARSON SM GRAHAM MC DIRESTA GR YEH SDJ MACAPINLAC H FINN RD ARBIT E CHEUNG NKV
Citation: F. Daghighian et al., DEVELOPMENT OF A METHOD TO MEASURE KINETICS OF RADIOLABELED MONOCLONAL-ANTIBODY IN HUMAN TUMOR WITH APPLICATIONS TO MICRODOSIMETRY - POSITRON EMISSION TOMOGRAPHY STUDIES OF I-124 LABELED 3F8 MONOCLONAL-ANTIBODY IN GLIOMA, European journal of nuclear medicine, 20(5), 1993, pp. 402-409
3-DIMENSIONAL DOSIMETRY FOR RADIOIMMUNOTHERAPY TREATMENT PLANNING
Authors: SGOUROS G CHIU S PENTLOW KS BREWSTER LJ KALAIGIAN H BALDWIN B DAGHIGHIAN F GRAHAM MC LARSON SM MOHAN R
Citation: G. Sgouros et al., 3-DIMENSIONAL DOSIMETRY FOR RADIOIMMUNOTHERAPY TREATMENT PLANNING, The Journal of nuclear medicine, 34(9), 1993, pp. 1595-1601
I-131 M195 (ANTI-CD33) RADIOIMMUNOTHERAPY TRIALS IN PATIENTS WITH MYELOID LEUKEMIAS
Authors: LARSON SM SCOTT AM DIVGI CR FINN RD GRAHAM MC SGOUROS G SCHEINBERG DA
Citation: Sm. Larson et al., I-131 M195 (ANTI-CD33) RADIOIMMUNOTHERAPY TRIALS IN PATIENTS WITH MYELOID LEUKEMIAS, The Journal of nuclear medicine, 34(5), 1993, pp. 53-53
Risultati: 1-25 | 26-31